117 related articles for article (PubMed ID: 12932707)
1. Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Nakade A; Tsuruda T; Sonobe T
J Control Release; 2003 Sep; 91(3):271-80. PubMed ID: 12932707
[TBL] [Abstract][Full Text] [Related]
2. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome.
Sadzuka Y; Nakade A; Hirama R; Miyagishima A; Nozawa Y; Hirota S; Sonobe T
Int J Pharm; 2002 May; 238(1-2):171-80. PubMed ID: 11996821
[TBL] [Abstract][Full Text] [Related]
3. [Characterization and cytotoxicity of mixed PEG-DSG modified liposomes].
Sadzuka Y; Tsuruda T; Sonobe T
Yakugaku Zasshi; 2005 Jan; 125(1):149-57. PubMed ID: 15635286
[TBL] [Abstract][Full Text] [Related]
4. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel mixed polyethyleneglycol modified liposomes.
Sugiyama I; Sadzuka Y
Biol Pharm Bull; 2007 Jan; 30(1):208-11. PubMed ID: 17202690
[TBL] [Abstract][Full Text] [Related]
6. Does the amount of an antitumor agent entrapped in liposomes influence its tissue distribution and cell uptake?
Sadzuka Y; Hirota S
Cancer Lett; 1998 Sep; 131(2):163-70. PubMed ID: 9851249
[TBL] [Abstract][Full Text] [Related]
7. Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes.
Sugiyama I; Sadzuka Y
Curr Drug Discov Technol; 2011 Dec; 8(4):357-66. PubMed ID: 22034853
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin.
Sugiyama I; Sadzuka Y
Int J Pharm; 2013 Jan; 441(1-2):279-84. PubMed ID: 23194885
[TBL] [Abstract][Full Text] [Related]
9. [An importance of colloid chemical characterization of liposomes for DDS in a large scale production].
Hirota S
Yakugaku Zasshi; 1997 Dec; 117(12):991-1005. PubMed ID: 9437906
[TBL] [Abstract][Full Text] [Related]
10. Effect of hybridized liposome by novel modification with some polyethyleneglycol-lipids.
Sugiyama I; Sonobe T; Sadzuka Y
Int J Pharm; 2009 May; 372(1-2):177-83. PubMed ID: 19429278
[TBL] [Abstract][Full Text] [Related]
11. [To Assess Drug Delivery System Nanocarrier at Industrial Production: Establishment of Liposomal Surface Using Physicochemical Properties].
Sadzuka Y
Yakugaku Zasshi; 2024; 144(1):61-69. PubMed ID: 38171797
[TBL] [Abstract][Full Text] [Related]
12. Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.
Sadzuka Y; Kishi K; Hirota S; Sonobe T
J Liposome Res; 2003 May; 13(2):157-72. PubMed ID: 12855110
[TBL] [Abstract][Full Text] [Related]
13. Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids.
Sugiyama I; Sadzuka Y
Biol Pharm Bull; 2013; 36(6):900-6. PubMed ID: 23727913
[TBL] [Abstract][Full Text] [Related]
14. Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin.
Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
Cancer Lett; 1997 Jan; 111(1-2):77-86. PubMed ID: 9022131
[TBL] [Abstract][Full Text] [Related]
15. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes.
Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
J Drug Target; 1995; 3(1):31-7. PubMed ID: 7655818
[TBL] [Abstract][Full Text] [Related]
16. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.
Yokoe J; Sakuragi S; Yamamoto K; Teragaki T; Ogawara K; Higaki K; Katayama N; Kai T; Sato M; Kimura T
Int J Pharm; 2008 Apr; 353(1-2):28-34. PubMed ID: 18082345
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD
J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
19. Effects of intraperitoneal administration of liposomes and methods of preparing liposomes for local therapy.
Sadzuka Y; Hirama R; Sonobe T
Toxicol Lett; 2002 Jan; 126(2):83-90. PubMed ID: 11751012
[TBL] [Abstract][Full Text] [Related]
20. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
